We are live on ! Find out more
PR

PSP Research Portfolio holdings

AUM $188M Turnover 26.97%
This Fund
S&P 500
This Quarter Est. Return
+18.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
–
Cap. Flow
+$110M
Cap. Flow %
96.55%
Top 10 Hldgs %
65.84%
Holding
85
New
85
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$70.3M
2
LEGN icon
Legend Biotech
LEGN
+$699K
3
ACLX icon
Arcellx
ACLX
+$656K
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$601K
5
MLYS icon
Mineralys Therapeutics
MLYS
+$594K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.41%
2 Healthcare 38.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IMCR icon
76
Immunocore
IMCR
$1.51B
$501K 0.44%
+14,424
New +$509K
2025 Q4
0 quarters
KYMR icon
77
Kymera Therapeutics
KYMR
$8.71B
$494K 0.43%
+6,348
New +$429K
2025 Q4
0 quarters
UPB icon
78
Upstream Bio Inc
UPB
$151M
$479K 0.42%
+17,634
New +$439K
2025 Q4
0 quarters
OLMA icon
79
Olema Pharmaceuticals
OLMA
$576M
$477K 0.42%
+19,063
New +$339K
2025 Q4
0 quarters
COGT icon
80
Cogent Biosciences
COGT
$5.12B
$470K 0.41%
+13,233
New +$372K
2025 Q4
0 quarters
GPCR icon
81
Structure Therapeutics
GPCR
$1.5B
$467K 0.41%
+6,719
New +$274K
2025 Q4
0 quarters
DFTX icon
82
Definium Therapeutics
DFTX
$4.31B
$467K 0.41%
+34,841
New +$431K
2025 Q4
0 quarters
ARWR icon
83
Arrowhead Research
ARWR
$7.9B
$444K 0.39%
+6,689
New +$328K
2025 Q4
0 quarters
ALMS icon
84
Alumis Inc
ALMS
$792M
$427K 0.37%
+43,769
New +$306K
2025 Q4
0 quarters
DYN icon
85
Dyne Therapeutics
DYN
$2.66B
$421K 0.37%
+21,535
New +$408K
2025 Q4
0 quarters
1 2 3
4

Similar funds

IJWM
Inman Jager Wealth Management Hattiesburg, Mississippi $188M AUM 19.49% 1-Year Est. Return
TCPG
Trivant Custom Portfolio Group San Diego, California $188M AUM 23.55% 1-Year Est. Return
KCPT
Kingstone Capital Partners Texas Frisco, Texas $188M AUM 26.67% 1-Year Est. Return
RMSCM
R.M. Sincerbeaux Capital Management New York $188M AUM 12.59% 1-Year Est. Return
AWP
Astra Wealth Partners Jersey City, New Jersey $188M AUM 26.79% 1-Year Est. Return
CFP
Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return
TCM
Thoma Capital Management Towson, Maryland $188M AUM 21.1% 1-Year Est. Return
TFP
Traction Financial Partners Encampment, Wyoming $188M AUM 20.42% 1-Year Est. Return

PSP Research's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for PSP Research, which disclosed 85 positions worth $114M. Its ten largest holdings account for 66% of the portfolio.

Its largest position is iShares 0-3 Month Treasury Bond ETF: 700,000 shares worth $70.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, followed by Healthcare.

  • PSP Research's largest Q4 2025 buy was iShares 0-3 Month Treasury Bond ETF: 700,000 shares worth $70.3M.
  • PSP Research's ten largest holdings make up 66% of its $114M portfolio in Q4 2025.
  • PSP Research disclosed 85 positions in Q4 2025, its first 13F filing on record.

Based on PSP Research's 13F filing for Q4 2025, filed 6 Feb 2026.